Blood News and Research

RSS

U.S., Norway announce new private-public initiative to improve maternal health in developing countries

Speaking at a health conference in Norway on Friday, U.S. Secretary of State Hillary Clinton announced the United States would provide $75 million a new private-public effort, dubbed "Saving Mothers, Giving Life," which aims "to improve the health of mothers and their babies in developing countries," Agence France-Presse reports.

5 Jun 2012

Researchers identify predictive biomarker for Parkinson's disease

Because there is currently no laboratory test that can diagnose Parkinson's disease, it is practically impossible to detect those individuals who are in the earliest stages of the disease. As a result, Parkinson's disease can only be diagnosed by a clinical neurological examination based on findings suggestive of the disease.

5 Jun 2012

ASS234 molecule inhibits aggregation of the Alzheimer's protein

Researchers at Universitat Aut-noma de Barcelona (UAB), the Spanish National Research Council (CSIC) and the University of Barcelona (UB) have developed a multitarget molecule, ASS234, which according to the results of in vitro studies conducted, inhibits the aggregation of the --amyloid protein, involved in Alzheimer's disease.

5 Jun 2012

Researchers uncover brain signaling pathway responsible for renal excretory function

Boston University School of Medicine (BUSM) researchers recently uncovered a brain signaling pathway responsible for regulating the renal excretion of sodium. The findings appear in the Journal of the Federation of American Societies for Experimental Biology.

5 Jun 2012

Caffeine/coffee intake associated with reduced risk of dementia or delayed onset

Those cups of coffee that you drink every day to keep alert appear to have an extra perk - especially if you're an older adult. A recent study monitoring the memory and thinking processes of people older than 65 found that all those with higher blood caffeine levels avoided the onset of Alzheimer's disease in the two-to-four years of study follow-up. Moreover, coffee appeared to be the major or only source of caffeine for these individuals.

5 Jun 2012

New algorithm can help ED physicians to reduce number of heart failure deaths

Physicians can reduce the number of heart failure deaths and unnecessary hospital admissions by using a new computer-based algorithm developed at the Institute for Clinical Evaluative Sciences (ICES) that calculates each patient's individual risk of death. Published in the Annals of Internal Medicine, the algorithm improves upon clinical decision-making and determines whether or not a patient with heart failure should be admitted to hospital.

5 Jun 2012

FDA approves Arteriocyte’s ACD-A for use with Magellan system

Arteriocyte Medical Systems, Inc. announced today approval by the U.S. Food and Drug Administration (FDA) to manufacture and distribute the Arteriocyte Medical Systems brand of Anticoagulant Citrate Dextrose Solution, USP (ACD-A) for use with its Magellan Platelet Separation System.

5 Jun 2012

MitrAssist receives ISO certification for design and development of mitral valve prosthesis

MitrAssist Medical Ltd., a developer of minimally invasive products for treating heart disease, announced today that it received ISO 13485:2003 Certification for the design and development of implantable heart valve prostheses.

4 Jun 2012

High levels of antibody molecule linked to increased rates of death from all diseases

Mayo Clinic researchers have identified an immune system deficiency whose presence shows someone is up to four times likelier to die than a person without it. The glitch involves an antibody molecule called a free light chain; people whose immune systems produce too much of the molecule are far more likely to die of a life-threatening illness such as cancer, diabetes and cardiac and respiratory disease than those whose bodies make normal levels. The study is published in the June issue of Mayo Clinic Proceedings.

4 Jun 2012

Variation in microRNAs may explain survival differences in breast cancer

Researchers and doctors at the North Shore-LIJ Health System and the Feinstein Institute for Medical Research have discovered a potential explanation for why breast cancer is not experienced the same way with African American and Caucasian patients.

4 Jun 2012

Algal DHA supplementation benefits during pregnancy and infancy

Positive results from clinical trials exploring algal DHA supplementation during pregnancy and infancy were presented this week at the 10th Congress of the International Society for the Study of Fatty Acids and Lipids (ISSFAL) – an international scientific society focused on research of dietary fats, oils and lipids.

2 Jun 2012

Patients with normal lipoprotein(a) levels may retain risk of atherosclerosis due to elevated LDL-P number

LipoScience, Inc., an in vitro diagnostic company advancing patient care by developing high value proprietary clinical diagnostic tests using nuclear magnetic resonance (NMR) technology, today announced results from a clinical study demonstrating that patients with normal levels of lipoprotein(a) may retain significant risk of atherosclerosis due to an elevated low density lipoprotein particle (LDL-P) number.

2 Jun 2012

New molecular test panel to enhance reliability of thyroid biopsy testing

Quest Diagnostics, the world's leading provider of diagnostic testing, information and services, today announced a new molecular test panel designed to help physicians determine if a thyroid gland is cancerous and requires surgical removal.

From Quest Diagnostics 2 Jun 2012

Lapatinib-pazopanib combination therapy not beneficial for patients with inflammatory breast cancer

Inflammatory breast cancer is a very aggressive type of cancer associated with early metastasis and poor survival rates, and the prognosis is even worse for patients with tumors expressing the ErbB2 receptor. The ErbB2-inhibiting drug lapatinib can slow the spread of cancer cells in individuals with advanced breast cancer who have already tried other chemotherapy medications.

2 Jun 2012

Chagas disease could pose threat similar to other global pandemics, experts warn

"Researchers are warning that the little-known Chagas disease could pose a threat similar to other global pandemics," Fox News reports, noting Chagas disease "is a parasitic illness that is most commonly transmitted by the so-called 'kissing bugs,' a subfamily of blood-sucking insects, through the parasite called Trypanosoma cruzi" (5/31).

2 Jun 2012

Reumofan Plus may have harmful pharmaceutical ingredients, warns FDA

The U.S. Food and Drug Administration is warning consumers that Reumofan Plus, marketed as a "natural" dietary supplement for pain relief and other serious conditions, contains several active pharmaceutical ingredients not listed on the label that could be harmful.

2 Jun 2012

Research roundup: Changing unhealthy diets with mobile tech; ACOs for Medicaid

Multiple Behavior Changes In Diet And Activity -- Mobile technologies have been touted for their potential benefits to health and wellness. Researchers in this study gave 204 individuals a dieting and exercise regimen. They also gave each person a handheld device to record adherence and receive remote coaching.

2 Jun 2012

Local anesthetic mixed with magnetized 'ferrofluids' may prevent rare complication of spinal anesthesia

An simple technique using local anesthetic mixed with magnetized "ferrofluids" may provide a new approach to preventing a rare but serious complication of spinal anesthesia, reports the June issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).

2 Jun 2012

Clinical trial to examine effectiveness of combined vaccine and hormone treatment for prostate cancer

Investigators at The Cancer Institute of New Jersey (CINJ) have partnered with the National Cancer Institute (NCI) and launched a clinical trial examining the effectiveness of a combined vaccine and hormone treatment for prostate cancer that is resistant to hormone therapy and not visible on imaging tests such as a CT scan and a bone scan.

2 Jun 2012

IPD connector outperforms negative pressure, split-septum needleless IV connector

InVision-Plus with Neutral Advantage Technology outperformed a negative pressure, split-septum needleless IV connector in a prospective study that examined the association of different IV connector types with catheter-related bloodstream infection (CR-BSI) rates.

2 Jun 2012

Blood News and Research

U.S., Norway announce new private-public initiative to improve maternal health in developing countries

Researchers identify predictive biomarker for Parkinson's disease

ASS234 molecule inhibits aggregation of the Alzheimer's protein

Researchers uncover brain signaling pathway responsible for renal excretory function

Caffeine/coffee intake associated with reduced risk of dementia or delayed onset

New algorithm can help ED physicians to reduce number of heart failure deaths

FDA approves Arteriocyte’s ACD-A for use with Magellan system

MitrAssist receives ISO certification for design and development of mitral valve prosthesis

High levels of antibody molecule linked to increased rates of death from all diseases

Variation in microRNAs may explain survival differences in breast cancer

Algal DHA supplementation benefits during pregnancy and infancy

Patients with normal lipoprotein(a) levels may retain risk of atherosclerosis due to elevated LDL-P number

New molecular test panel to enhance reliability of thyroid biopsy testing

Lapatinib-pazopanib combination therapy not beneficial for patients with inflammatory breast cancer

Chagas disease could pose threat similar to other global pandemics, experts warn

Reumofan Plus may have harmful pharmaceutical ingredients, warns FDA

Research roundup: Changing unhealthy diets with mobile tech; ACOs for Medicaid

Local anesthetic mixed with magnetized 'ferrofluids' may prevent rare complication of spinal anesthesia

Clinical trial to examine effectiveness of combined vaccine and hormone treatment for prostate cancer

IPD connector outperforms negative pressure, split-septum needleless IV connector

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News